Meros Investment Management, LP Harvard Bioscience Inc Transaction History
Meros Investment Management, LP
- $208 Million
- Q2 2024
A detailed history of Meros Investment Management, LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Meros Investment Management, LP holds 835,213 shares of HBIO stock, worth $2.05 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
835,213
Previous 821,792
1.63%
Holding current value
$2.05 Million
Previous $3.48 Million
31.69%
% of portfolio
1.15%
Previous 1.58%
Shares
11 transactions
Others Institutions Holding HBIO
# of Institutions
103Shares Held
32MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$7 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$6.82 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$6.29 Million0.9% of portfolio
-
Amh Equity LTD2.2MShares$5.41 Million8.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.21 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $102M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...